Submitted by Anonymous on November 8, 2017 - 4:39pm
"Ferroptosis Modulation and (Patho)physiological Relevance"
Marcus Conrad, Ph.D.
Research Group Leader, Drug Discovery
Institute of Developmental Genetics, Helmholtz Zentrum Munchen
German Research Center for Environmental Health, Munich, Germany
Hosts: Xuejun Jiang and Michael Overholtzer
Tea: 10:15 a.m.
Date:
Monday, November 27, 2017 - 10:30am to 11:30am